A Phase III Study of First-line Anlotinib Combined With Benmelstobart in Patients With Advanced Esophageal Squamous Cell Carcinoma
Clinical trial NCT07446335 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07446335
- Sponsor
- The First Affiliated Hospital of Zhengzhou University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-01
- Primary completion
- 2028-12-01
- Enrollment
- 578
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.